| First Author | Muro R | Year | 2024 |
| Journal | J Clin Invest | Volume | 134 |
| Issue | 20 | PubMed ID | 39403924 |
| Mgi Jnum | J:360882 | Mgi Id | MGI:7750252 |
| Doi | 10.1172/JCI179612 | Citation | Muro R, et al. (2024) Transcript splicing optimizes the thymic self-antigen repertoire to suppress autoimmunity. J Clin Invest 134(20) |
| abstractText | Immunological self-tolerance is established in the thymus by the expression of virtually all self-antigens, including tissue-restricted antigens (TRAs) and cell-type-restricted antigens (CRAs). Despite a wealth of knowledge about the transcriptional regulation of TRA genes, posttranscriptional regulation remains poorly understood. Here, we show that protein arginine methylation plays an essential role in central immune tolerance by maximizing the self-antigen repertoire in medullary thymic epithelial cells (mTECs). Protein arginine methyltransferase-5 (Prmt5) was required for pre-mRNA splicing of certain key genes in tolerance induction, including Aire as well as various genes encoding TRAs. Mice lacking Prmt5 specifically in thymic epithelial cells exhibited an altered thymic T cell selection, leading to the breakdown of immune tolerance accompanied by both autoimmune responses and enhanced antitumor immunity. Thus, arginine methylation and transcript splicing are essential for establishing immune tolerance and may serve as a therapeutic target in autoimmune diseases as well as cancer immunotherapy. |
